A 4×500 mm2 cloverleaf detector system for in vivo bone lead measurement

Medical Physics

Volumn 34, Issue 3, 2007, Pages 945-951

  Fleming, David E B ^a   Mills, Caitlin E ^a  

^a MOUNT ALLISON UNIVERSITY   (Canada)

Author keywords

Bone lead; Cloverleaf detector; X ray fluorescence

Indexed keywords

BONE; FLUORESCENCE; PHANTOMS; UNCERTAINTY ANALYSIS; X RAYS;

DETECTOR SYSTEMS; EQUIVALENT SURFACE AREAS; GERMANIUM DETECTOR; HIGH ACTIVITY; IN-VIVO; REPRODUCIBILITIES; X RAY FLUORESCENCE;

X RAY DETECTORS;

CADMIUM 109; LEAD; CADMIUM; GERMANIUM;

ANTENNA; ARTICLE; BONE RADIOGRAPHY; IN VIVO STUDY; MEASUREMENT; PRIORITY JOURNAL; REPRODUCIBILITY; SIMULATION; SURFACE PROPERTY; TIBIA; X RAY FLUORESCENCE; BONE; CHEMISTRY; CYCLOTRON; ENVIRONMENTAL EXPOSURE; HUMAN; IMAGE QUALITY; INSTRUMENTATION; LEAD POISONING; METABOLISM; METHODOLOGY; SENSITIVITY AND SPECIFICITY; SPECTROMETRY;

BONE AND BONES; CADMIUM RADIOISOTOPES; CYCLOTRONS; ENVIRONMENTAL EXPOSURE; GERMANIUM; HUMANS; LEAD; LEAD POISONING; PHANTOMS, IMAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, X-RAY EMISSION;

EID: 33847655090     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2436973     Document Type: Article

References (30)

1. S. Tong, Y. E. von Schirnding, and T. Prapamontol, " Environmental lead exposure: a public health problem of global dimensions., " Bull. World Health Organ 78, 1068-1077 (2000).
2. B. S. Glenn, W. F. Stewart, J. M. Links, A. C. Todd, and B. S. Schwartz, " The longitudinal association of lead with blood pressure., " Epidemiology 14, 30-36 (2003).
3. M. B. Rabinowitz, " Toxicokinetics of bone lead., " Environ. Health Perspect. 91, 33-37 (1991).
4. P. S. I. Barry, " A comparison of concentrations of lead in human tissues., " Br. J. Ind. Med. 32, 119-139 (1975).
5. S. B. Gross, E. A. Pfitzer, D. W. Yeager, and R. A. Kehoe, " Lead in human tissues., " Toxicol. Appl. Pharmacol. 32, 638-651 (1975).
6. J. A. A. Brito, F. E. McNeill, I. Stronach, C. E. Webber, S. Wells, N. Richard, and D. R. Chettle, " Longitudinal changes in bone lead concentration: Implications for modeling of human bone lead metabolism., " J. Environ. Monit. 3, 343-351 (2001).
7. W. F. Stewart, B. S. Schwartz, D. Simon, K. I. Bolla, A. C. Todd, and J. Links, " Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workers., " Neurology 52, 1610-1616 (1999).
8. B. S. Schwartz, W. F. Stewart, K. I. Bolla, D. Simon, K. Bandeen-Roche, B. Gordon, J. M. Links, and A. C. Todd, " Past adult lead exposure is associated with longitudinal decline in cognitive function., " Neurology 55, 1144-1150 (2000).
9. Y. Cheng, J. Schwartz, D. Sparrow, A. Aro, S. T. Weiss, and H. Hu, " Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension: The normative aging study., " Am. J. Epidemiol. 153, 164-171 (2001).
10. T. Gonzalez-Cossio, K. E. Peterson, L.-H. Sanin, E. Fishbein, E. Palazeulos, A. Aro, M. Hernandez-Avila, and H. Hu, " Decrease in birth weight in relation to maternal bone lead., " Pediatrics 100, 856-862 (1997).
11. P. B. Hoffer, W. B. Jones, R. B. Crawford, R. Beck, and A. Gottschalk, " Fluorescent thyroid scanning: A new method of imaging the thyroid., " Radiology 90, 342-344 (1968).
12. L. Ahlgren, K. Liden, S. Mattsson, and S. Tejning, " X-ray fluorescence analysis of lead in human skeleton in vivo., " Scand. J. Work Environ. Health 2, 82-86 (1976).
13. E. E. Laird, D. R. Chettle, and M. C. Scott, " The factors affecting in vivo x-ray fluorescence measurements of lead in bone., " Nucl. Instrum. Methods Phys. Res. 193, 377-382 (1982).
14. L. J. Somervaille, D. R. Chettle, and M. C. Scott, " In vivo measurement of lead in bone using x-ray fluorescence., " Phys. Med. Biol. 30, 929-943 (1985).
15. C. L. Gordon, D. R. Chettle, and C. E. Webber, " An improved instrument for the in vivo detection of bone lead., " Br. J. Ind. Med. 50, 637-641 (1993).
16. A. C. Todd and D. R. Chettle, " In vivo X-ray fluorescence of lead in bone: Review and current issues., " Environ. Health Perspect. 102, 172-177 (1994).
17. H. Nie, D. Chettle, I. Stronach, M. Arnold, S. Huang, F. McNeill, and J. O'Meara, " A study of MDL improvement for the in vivo measurement of lead in bone., " Nucl. Instrum. Methods Phys. Res. B 213, 579-583 (2004).
18. H. Nie, D. Chettle, L. Luo, and J. O'Meara, " In vivo investigation of a new Cd109 γ -ray induced K-XRF bone lead measurement system., " Phys. Med. Biol. 51, 351-360 (2006).
19. N. Ahmed and D. E. B. Fleming, " Early experiences with the Mount Allison University four-detector X-ray fluorescence bone lead measurement system., " Nucl. Instrum. Methods Phys. Res. B (accepted for publication).
20. A. C. A. Aro, A. C. Todd, C. Amarasiriwardena, and H. Hu, " Improvements in the calibration of Cd109 K x-ray fluorescence systems for measuring bone lead in vivo., " Phys. Med. Biol. 39, 2263-2271 (1994).
21. D. E. B. Fleming and T. A. Forbes, " Calibration and characterization of a digital X-ray fluorescence bone lead system., " Appl. Radiat. Isot. 55, 527-532 (2001).
22. N. Ahmed, D. E. B. Fleming, D. Wilkie, and J. M. O'Meara, " Effects of overlying soft tissue on X-ray fluorescence bone lead measurement uncertainty., " Radiat. Phys. Chem. 75, 1-6 (2006).
23. A. Pejovic-Milic, J. A. Brito, J. Gyorffy, and D. R. Chettle, " Ultrasound measurements of overlying soft tissue thickness at four skeletal sites suitable for in vivo x-ray fluorescence., " Med. Phys. 29, 2687-2691 (2002).
24. A. C. Todd and D. R. Chettle, " Calculating the uncertainty in lead concentration for in vivo bone lead x-ray fluorescence., " Phys. Med. Biol. 48, 2033-2045 (2003).
25. J. A. Hoppin, A. Aro, H. Hu, and P. B. Ryan, " Measurement variability associated with KXRF bone lead measurement in young adults., " Environ. Health Perspect. 108, 239-242 (2000).
26. A. C. Todd, S. Carroll, J. H. Godbold, E. L. Moshier, and F. A. Khan, " Variability in XRF-measured tibia lead levels., " Phys. Med. Biol. 45, 3737-3748 (2000).
27. D. E. B. Fleming, D. R. Chettle, F. E. McNeill, and A. G. P. Weedon, " Effects of measurement distance and source activity on the precision of X-ray fluorescence measurements of lead in a bone phantom., " Nucl. Instrum. Methods Phys. Res. B 217, 471-478 (2004).
28. D. E. B. Fleming, D. R. Chettle, C. E. Webber, and E. J. O'Flaherty, " The O'Flaherty model of lead kinetics: An evaluation using data from a lead smelter population., " Toxicol. Appl. Pharmacol. 161, 100-109 (1999).
29. J. A. A. Brito, F. E. McNeill, C. E. Webber, S. Wells, N. Richard, M. L. Carvalho, and D. R. Chettle, " Evaluation of a novel structural model to describe the endogenous release of lead from bone., " J. Environ. Monit. 4, 194-201 (2002).
30. H. Nie, D. R. Chettle, C. E. Webber, J. A. A. Brito, J. M. O'Meara, and F. E. McNeill, " The study of age influence on human bone lead metabolism by using a simplified model and X-ray fluorescence data., " J. Environ. Monit. 7, 1069-1073 (2005).